NASDAQ:IMV
Delisted
IMV Inc. Stock News
$0.82
+0 (+0%)
At Close: Jul 27, 2023
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)---- $IMV #Cancer--IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of
IMV Inc. to Present at Two Upcoming Investor Conferences
07:05am, Thursday, 13'th May 2021
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. to present at two upcoming Investor Conferences
IMV Inc. (IMV) CEO Fred Ors on Q1 2021 Results - Earnings Call Transcript
01:50pm, Wednesday, 12'th May 2021
IMV Inc. (IMV) CEO Fred Ors on Q1 2021 Results - Earnings Call Transcript
IMV Inc. Announces First Quarter 2021 Financial and Operational Results and Expansion of its Clinical Pipeline
07:05am, Wednesday, 12'th May 2021
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. (the “Company” or “IMV”) (TSX: IMV; NASDAQ: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, toda
IMV Appoints Dr. Michael Kalos to Board of Directors
07:05am, Tuesday, 11'th May 2021
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)---- $IMV #Cancer--IMV Inc. (the "Company" or "IMV") (NASDAQ: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherap
IMV Stock: Over 9% Increase Pre-Market Explanation
08:47am, Monday, 10'th May 2021
The stock price of Imv Inc (NASDAQ: IMV) increased by over 9% pre-market. This is why it happened.
IMV's Lead Immunotherapy to be Investigated in Breast Cancer
07:05am, Monday, 10'th May 2021
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)---- $IMV #BreastCancer--IMV Inc. (Nasdaq: IMV; TSX: IMV) (“IMV” or the “Company”), a clinical-stage biopharmaceutical company pioneering a novel class o
IMV Inc. to Announce First Quarter 2021 Results and Host a Conference Call and Webcast on May 12, 2021
07:05am, Thursday, 29'th Apr 2021
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV to announce First Quarter 2021 Results and host conference call and Webcast on May 12, 2021
IMV Inc. to Present at the Bloom Burton & Co. Healthcare Investor Virtual Conference
07:05am, Tuesday, 13'th Apr 2021
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. to Present at the Bloom Burton & Co. Healthcare Investor Virtual Conference
Do Options Traders Know Something About IMV Stock We Don't?
09:05am, Friday, 09'th Apr 2021
Investors need to pay close attention to IMV stock based on the movements in the options market lately.
IMV Announces Company-Sponsored Clinical Trial in Patients with r/rDLBCL in Collaboration with Merck Following Feedback from FDA
07:05am, Wednesday, 07'th Apr 2021
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)-- #DLBCL--IMV Inc. (Nasdaq: IMV; TSX: IMV) (“IMV” or the “Company”), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immun
IMV Appoints Kyle Kuvalanka to Board of Directors
07:05am, Thursday, 25'th Mar 2021
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)---- $IMV--IMV Inc. (the "Company" or "IMV") (NASDAQ: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, tod
IMV Inc. (IMV) CEO Fred Ors on Q4 2020 Results - Earnings Call Transcript
12:32pm, Wednesday, 17'th Mar 2021
IMV Inc. (IMV) CEO Fred Ors on Q4 2020 Results - Earnings Call Transcript
IMV Inc. Announces Fourth Quarter and Full Year 2020 Financial and Operational Results
07:05am, Wednesday, 17'th Mar 2021
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)---- $IMV--IMV Inc. (the “Company” or “IMV”) (TSX: IMV; NASDAQ: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherap
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV to Announce Fourth Quarter and Fiscal 2020 Financial and Operational Results
